Arthritis September 2012 Archive

Approximately 8.3 million American adults have gout. While gout treatment is available, many people still suffer with recurrent gout attacks. According to study results published online September 28, 2012 in ... Read More

Are you a night owl? Do you watch television late at night? If you answered yes, you probably have encountered the infomerical for Nopalea. I had never heard of Nopalea ... Read More

The maker of Simponi (golimumab), a biologic drug used to treat moderate-to-severe rheumatoid arthritis, active psoriatic arthritis, and active ankylosing spondylitis, has submitted an application to the FDA for approval ... Read More

For years, many people have used Tylenol to manage their pain. Tylenol is arguably the most popular over-the-counter pain reliever. But many people have had trouble finding Tylenol on their ... Read More

The FDA is warning people who use topical pain relievers that the products may cause rare cases of first-to-third degree chemical burns where the product was applied. The topical pain ... Read More

There is more evidence that suggests the anti-inflammatory effect of TNF blockers, used to treat inflammatory types of arthritis, decreases cardiovascular risk in patients with rheumatoid arthritis, according to a ... Read More

For some time, there have been questions and concerns about the potential development of malignancies in rheumatoid arthritis patients treated with biologic drugs. According to results published in the September ... Read More

Several blood tests are associated with high rates of false positive results for connective tissue diseases. The tests, also referred to as autoimmune serology tests, are commonly ordered for people ... Read More